Quest Diagnostics Inc. (QDI)
Summary
QDI Chart
Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?
Here is how Quest Diagnostics (DGX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
Quest Diagnostics Inc. (QDI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Quest Diagnostics Inc. ever had a stock split?
Quest Diagnostics Inc. Profile
| Professional Services Industry | Industrials Sector | James E. Davis CEO | XFRA Exchange | US74834L1008 ISIN |
| US Country | 55,000 Employees | 8 Jul 2026 Last Dividend | 21 Jun 2005 Last Split | 17 Dec 1996 IPO Date |
Overview
Quest Diagnostics Incorporated, established in 1967 and based in Secaucus, New Jersey, is a prominent provider of diagnostic testing, information, and services both in the United States and internationally. The company operates with the mission to deliver critical diagnostic insights that lead to informed healthcare decisions. Using its extensive network of laboratories, patient service centers, and healthcare professionals, Quest Diagnostics offers a wide range of diagnostic information services. These services cater to a diverse clientele including physicians, hospitals, patients, health plans, government agencies, employers, and pharmaceutical companies. Through its flagship Quest Diagnostics brand and others such as AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum, the company aims to improve health outcomes by making better information available to the healthcare ecosystem.
Products and Services
- Diagnostic Information Services
- Risk Assessment Services for Life Insurance Industry
- Healthcare Information Technology Solutions
These encompass routine and non-routine clinical tests, advanced clinical testing, and anatomic pathology testing. Quest Diagnostics utilizes a vast array of technological platforms to provide critical diagnostic information that supports disease prevention, diagnosis, treatment, and management.
Quest Diagnostics provides comprehensive risk assessment services tailored to the needs of the life insurance sector. These services are designed to help insurance companies evaluate the health risks of policy applicants through a variety of diagnostic tests and assessments.
Offering cutting-edge information technology solutions, Quest Diagnostics helps healthcare organizations and clinicians enhance efficiency and patient care. These solutions encompass a wide range of IT services designed to facilitate the secure exchange of health information, improve lab ordering processes, and streamline patient record management.
